CUSIP: 19240Q201
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
155,716,944
-
Total 13F shares
-
173,924,687
-
Share change
-
+12,262,539
-
Total reported value
-
$6,178,412,345
-
Put/Call ratio
-
81%
-
Price per share
-
$35.52
-
Number of holders
-
265
-
Value change
-
+$561,964,404
-
Number of buys
-
174
-
Number of sells
-
84
Quarterly Holders Quick Answers
What is CUSIP 19240Q201?
CUSIP 19240Q201 identifies COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 19240Q201:
Institutional Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) as of Q4 2025
As of 31 Dec 2025,
Cogent Biosciences, Inc. - Common Stock, $0.001 par value per share (COGT) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
173,924,687 shares.
The largest 10 holders included
FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, RTW INVESTMENTS, LP, Kynam Capital Management, LP, TCG Crossover Management, LLC, STATE STREET CORP, and JANUS HENDERSON GROUP PLC.
This page lists
265
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.